Caption Management, LLC Albireo Pharma, Inc. Call Options Transaction History

Caption Management, LLC

3 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2022 May 13, 2022	BUY	$23.94 - $33.74 $2.27 Million - $3.21 Million	95,000 New	95,000 $2.83 Million
Q4 2020 Feb 16, 2021	SELL	$31.56 - $42.16 $2.55 Million - $3.41 Million	-80,800 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$23.19 - $41.61 $1.87 Million - $3.36 Million	80,800 New	80,800 $2.7 Million

865

Ticker ALBO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 19,612,500
Description
Albireo Pharma, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of novel bile acid modulators to treat orphan pediatric liver diseases and other liver or gastrointestinal diseases and disorders. The company offers Bylvay for the treatment of progressive familial intrahepatic cholestasis, as we...

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Caption Management, LLC with notifications on news.